The reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
8.05BCNY
1.20B · vs all stocks (USD)
Updated Sep 19, 2026
Revenue (TTM)
8.77BCNY
1.31B · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
-8.27%
Updated Sep 19, 2026
Beta
1.42x
vs all stocks
Updated Sep 19, 2026
52-Week Change
50.22%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
8.05BCNY
1.20B · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
20.96BCNY
3.13B · vs all stocks (USD)
Updated Sep 19, 2026
Price to Sales (TTM)
0.8889x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.92×.Updated Sep 19, 2026
Price to Book (MRQ)
1.36x
Updated Sep 19, 2026
Enterprise to Revenue
2.39x
Updated Sep 19, 2026
Enterprise to EBITDA
80.96x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 23.55×.Updated Sep 19, 2026
Gross Margin
11.12%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 9.05%.Updated Sep 19, 2026
Profit Margin
-8.27%
Updated Sep 19, 2026
Operating Margin
-4.36%
Updated Sep 19, 2026
Return on Assets (TTM)
0.29%
Updated Sep 19, 2026
Return on Equity (TTM)
-5.57%
Updated Sep 19, 2026
Revenue (TTM)
8.77BCNY
1.31B · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
9.74CNYUpdated Sep 19, 2026
Quarterly Revenue Growth
-75.40%
Updated Sep 19, 2026
Gross Profit (TTM)
793.93MCNY
118.42M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
890.15MCNY
132.77M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
-725.38MCNY
-108.20M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
-70.64%
Updated Sep 19, 2026
Operating Cash Flow (TTM)
-2.82BCNY
-420.28M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
-2.37BCNY
-353.27M · vs all stocks (USD)
Updated Sep 19, 2026
5-Year Average Dividend Yield
1.09%
vs all stocks
Updated Sep 19, 2026
Payout Ratio
0.00%
Updated Sep 19, 2026
Minority Interest (Equity)
3.28BCNYFY2024 · Dec 31, 2024
Revenue
7.70BCNYFY2024 · Dec 31, 2024
Cost of Goods Sold
6.49BCNYFY2024 · Dec 31, 2024
Gross Profit
1.21BCNYFY2024 · Dec 31, 2024
Operating Income
764.91MCNY
114.09M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Pre-tax Income
296.76MCNYFY2024 · Dec 31, 2024
Income Tax Expense
201.09MCNYFY2024 · Dec 31, 2024
Net Income
95.67MCNYFY2024 · Dec 31, 2024
EBIT
536.55MCNYFY2024 · Dec 31, 2024
EBITDA (Income Statement)
890.15MCNYFY2024 · Dec 31, 2024
Selling, General & Administrative
254.53MCNYFY2024 · Dec 31, 2024
Other Operating Expenses
10.84MCNYFY2024 · Dec 31, 2024
Non-operating Interest Income
64.17MCNYFY2024 · Dec 31, 2024
Non-operating Interest Expense
239.79MCNYFY2024 · Dec 31, 2024
EPS (Basic)
-0.0700CNYFY2024 · Dec 31, 2024
EPS (Diluted)
-0.0700CNYFY2024 · Dec 31, 2024
Basic Shares Outstanding
808.18MSharesFY2024 · Dec 31, 2024
Diluted Shares Outstanding
808.18MSharesFY2024 · Dec 31, 2024
Net Income from Continuing Operations
95.67MCNYFY2024 · Dec 31, 2024
Minority Interests (P&L)
-152.25MCNYFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00CNYFY2024 · Dec 31, 2024
Operating Cash Flow
-2.93BCNYFY2024 · Dec 31, 2024
Free Cash Flow
-2.93BCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
5.24BCNYFY2024 · Dec 31, 2024
Starting Profit (CF Statement)
95.67MCNYFY2024 · Dec 31, 2024
Other Non-cash Items
179.61MCNYFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-2.32BCNYFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-877.82MCNYFY2024 · Dec 31, 2024
Capital Expenditures
-1.81MCNYFY2024 · Dec 31, 2024
Purchase of Investments
-482.75MCNYFY2024 · Dec 31, 2024
Sale of Investments
359.13MCNYFY2024 · Dec 31, 2024
Other Investing Activity
-395.77MCNYFY2024 · Dec 31, 2024
Net Investing Cash Flow
-521.20MCNYFY2024 · Dec 31, 2024
Long-term Debt Issuance
5.34BCNYFY2024 · Dec 31, 2024
Long-term Debt Payments
-4.04BCNYFY2024 · Dec 31, 2024
Common Dividends Paid
-398.12MCNYFY2024 · Dec 31, 2024
Other Financing Charges
1.34BCNYFY2024 · Dec 31, 2024
Net Financing Cash Flow
2.24BCNYFY2024 · Dec 31, 2024
Shares Outstanding
803.29MSharesUpdated Sep 19, 2026
Float Shares
329.43MSharesUpdated Sep 19, 2026
% Held by Insiders
61.54%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
1.22%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
3.08BCNY
460.05M · vs all stocks (USD)
Updated Sep 19, 2026
Total Cash per Share (MRQ)
3.84CNYUpdated Sep 19, 2026
Total Debt (MRQ)
12.79BCNY
1.91B · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
1.37x
Updated Sep 19, 2026
Current Ratio (MRQ)
2.19x
Updated Sep 19, 2026
Book Value per Share (MRQ)
7.16CNYUpdated Sep 19, 2026
Total Assets
38.73BCNY
5.78B · vs all stocks (USD)
FY2024 · Dec 31, 2024
Total Current Assets
34.93BCNYFY2024 · Dec 31, 2024
Total Liabilities
28.97BCNYFY2024 · Dec 31, 2024
Total Non-current Assets
3.79BCNYFY2024 · Dec 31, 2024
Total Non-current Liabilities
7.33BCNYFY2024 · Dec 31, 2024
Total Current Liabilities
21.64BCNYFY2024 · Dec 31, 2024
Cash
5.24BCNYFY2024 · Dec 31, 2024
Cash Equivalents
124.46MCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents
5.36BCNYFY2024 · Dec 31, 2024
Accounts Receivable
339.03MCNYFY2024 · Dec 31, 2024
Inventory
22.89BCNYFY2024 · Dec 31, 2024
Accounts Payable
2.44BCNYFY2024 · Dec 31, 2024
Short-term Debt
2.94BCNYFY2024 · Dec 31, 2024
Other Current Liabilities
1.12BCNYFY2024 · Dec 31, 2024
Long-term Debt
7.30BCNYFY2024 · Dec 31, 2024
Other Non-current Liabilities
702.51KCNYFY2024 · Dec 31, 2024
Common Stock (Book)
803.29MCNYFY2024 · Dec 31, 2024
Retained Earnings
3.34BCNYFY2024 · Dec 31, 2024
Total Shareholders' Equity
9.75BCNY
1.45B · vs all stocks (USD)
FY2024 · Dec 31, 2024
52-Week Low
6.38CNYUpdated Sep 19, 2026
52-Week High
26.36CNYUpdated Sep 19, 2026
52-Week Change
50.22%
vs all stocks
Updated Sep 19, 2026
Beta
1.42x
vs all stocks
Updated Sep 19, 2026
50-Day MA
11.80CNYUpdated Sep 19, 2026
200-Day MA
14.11CNYUpdated Sep 19, 2026
Avg 10-Day Volume
19.24MSharesUpdated Sep 19, 2026
Avg 30-Day Volume
30.55MSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
-0.9100CNYUpdated Sep 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.